Biotech Acquisition Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $231,556,621 last year. Net change in cash is therefore $91,407.
Cash Flow
| 2021 | -1.46M | -230M | 231.55M |
|---|
BIOTW Cash Flow Statement (2021 – 2021)
| 2021 | |
|---|---|
Cash at beginning of period | 0 |
Operating activities | |
Net income | -6.86M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 0 |
Stock-based compensation expense | 0 |
| Deferred income tax benefit | 0 |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | 0 |
Inventories | 0 |
Accounts payable | 0 |
Cash generated by operating activities | -1.46M |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | 0 |
Acquisitions Net | 0 |
Cash generated by investing activities | -230M |
Financing activities | |
Common Stock Issued | 226M |
Payments for dividends | 0 |
Repurchases of common stock | 0 |
Repayments of term debt | -155.41K |
Cash used in financing activities | 231.55M |
Net Change In Cash | 91.40K |
Cash at end of period | 91.40K |
| Data source |